Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcitonin

S L Silverman1

  • 1West Los Angeles VA Medical Center, UCLA, California 90073, USA.

The American Journal of the Medical Sciences
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Nasal calcitonin is a new osteoporosis treatment shown to be safe and potentially increase bone density. Further research is needed for fracture efficacy, but it may offer pain relief and benefits for specific osteoporosis types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Study of the Disputed Point in Local Anesthesia.

The Dental register·2021
Same author

Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Bisphosphonate drug holidays: we reap what we sow.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2014
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Osteoporosis is a significant public health concern.
  • Established treatments for osteoporosis exist, but new therapeutic options are continually sought.

Purpose of the Study:

  • To review the newly approved nasal calcitonin as a treatment for established osteoporosis.
  • To discuss its safety, potential efficacy, and dosing.

Main Methods:

  • Review of available clinical data and literature on nasal calcitonin for osteoporosis.
  • Analysis of safety profiles and preliminary efficacy findings.

Main Results:

  • Nasal calcitonin is a safe and preventative option for osteoporosis.
  • It may increase bone mineral density in the lumbar spine.

Related Experiment Videos

  • Preliminary data suggest potential analgesic effects and benefits in glucocorticoid-induced osteoporosis.

    • Conclusions:

    • Nasal calcitonin represents a promising new treatment for established osteoporosis.
    • While fracture efficacy data are pending, its safety and potential bone-preserving effects are notable.
    • Optimal dosing for prevention requires further investigation.